文献速递糖尿病

晚期糖基化终产物、氧化产物与动脉粥样硬化程度:VA糖尿病试验及随访研究

Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.
PubMed 文献 · Diabetes Care · 2017-02-01

在VA糖尿病试验及随访研究中,对411名2型糖尿病患者基线血浆晚期糖基化终产物和氧化产物进行检测,平均随访约10年后行颈动脉内膜中层厚度超声、冠状动脉钙化和腹主动脉钙化CT评估;风险因素校正后,G-H1与颈动脉内膜中层厚度和冠状动脉钙化程度相关,2-AAA与冠状动脉钙化程度强相关,CEL与腹主动脉钙化程度强相关,G-H1与2-AAA联合与所有亚临床动脉粥样硬化指标强相关。

要点

  • 在2型糖尿病患者中,基线G-H1与颈动脉内膜中层厚度和冠状动脉钙化程度相关。
  • 基线2-AAA与冠状动脉钙化程度强相关,CEL与腹主动脉钙化程度强相关。
  • G-H1与2-AAA联合与所有亚临床动脉粥样硬化指标强相关。

核心结论

  • 特定的晚期糖基化终产物和代谢氧化产物与长期亚临床动脉粥样硬化严重程度相关,并可能在长期2型糖尿病患者大血管并发症的「负代谢记忆」中起重要作用。

研究设计与样本

  • VA糖尿病试验及随访研究,共纳入411名参与者,检测基线血浆甲基乙二醛氢咪唑酮、Nε-羧甲基赖氨酸、Nε-羧乙基赖氨酸(CEL)、3-脱氧葡萄糖酮氢咪唑酮和乙二醛氢咪唑酮(G-H1)、2-氨基己二酸(2-AAA)及甲硫氨酸亚砜水平。
  • 参与者在平均随访10年后接受颈动脉内膜中层厚度(CIMT)超声评估、冠状动脉钙化(CAC)和腹主动脉钙化(AAC)计算机断层扫描。

主要发现

  • 在风险因素校正的多变量回归模型中,G-H1与CIMT和CAC程度相关。
  • 2-AAA与CAC程度强相关,CEL与AAC程度强相关。
  • G-H1与2-AAA联合与所有亚临床动脉粥样硬化指标强相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether plasma levels of advanced glycation end products and oxidation products play a role in the development of atherosclerosis in patients with type 2 diabetes (T2D) over nearly 10 years of the VA Diabetes Trial and Follow-up Study. RESEARCH DESIGN AND METHODS: Baseline plasma levels of methylglyoxal hydroimidazolone, Nε-carboxymethyl lysine, Nε-carboxyethyl lysine (CEL), 3-deoxyglucosone hydroimidazolone and glyoxal hydroimidazolone (G-H1), 2-aminoadipic acid (2-AAA), and methionine sulfoxide were measured in a total of 411 participants, who underwent ultrasound assessment of carotid intima-media thickness (CIMT), and computed tomography scanning of coronary artery calcification (CAC) and abdominal aortic artery calcification (AAC) after an average of 10 years of follow-up. RESULTS: In risk factor-adjusted multivariable regression models, G-H1 was associated with the extent of CIMT and CAC. In addition, 2-AAA was strongly associated with the extent of CAC, and CEL was strongly associated with the extent of AAC. The combination of specific advanced glycation end products and oxidation products (G-H1 and 2-AAA) was strongly associated with all measures of subclinical atherosclerosis. CONCLUSIONS: Specific advanced glycation end products and metabolic oxidation products are associated with the severity of subclinical atherosclerosis over the long term and may play an important role in the "negative metabolic memory" of macrovascular complications in people with long-standing T2D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Saremi A, Howell S, Schwenke DC, et al. Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study. Diabetes Care. 2017. PMID: 28148544. doi:10.2337/dc16-1875

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。